The global healthcare contract development and manufacturing organization market size is expected to reach USD 352.3 billion by 2027, registering a CAGR of 8.1% over the forecast period, according to a new report by Grand View Research, Inc. Increasing outsourcing of R&D is one of the major factors contributing to the market growth.
Healthcare contract development and manufacturing organization (CDMO) provides outsourcing services to various pharmaceutical industries on contract basis. Increase in the outsourcing by pharmaceutical companies, growing pharmaceutical industry, and support of CDMOs in reducing the operational and capital expenses are some of the major factors anticipated to propel the market growth over the forecast period.
For PDF sample Copy or More Details please visit link @: https://www.grandviewresearch.com/industry-analysis/healthcare-contract-development-manufacturing-organization-market
In addition, growing pressure on pharmaceutical and medical device companies to follow stringent timelines has increased the demand for outsourcing development and manufacturing activities to CDMOs. Further, due to increasing demand for medical devices in the emerging countries, various companies are shifting their focus on research and development and outsourcing of medical devices. Also, rise in outsourcing of R&D and growing competency of CDMOs are expected to further contribute to the growing demand for early stage development CDMOs by life science companies.
However, increasing logistic costs, serialization issues faced by healthcare organizations, and threat of infringement of Intellectual Property (IP) rights are anticipated to restrain the market growth for healthcare contract development & manufacturing organization over the forecast period.
Healthcare Contract Development & Manufacturing Organization Market Report Highlights
• The contract manufacturing segment dominated the market with a revenue share of 72.7% in 2019 due to increase in the outsourcing of manufacturing services by pharmaceutical and medical device companies
• The preclinical segment is expected to register the highest CAGR of 8.6% over the forecast period due to rising prevalence of many lifestyle-influenced diseases
• North America dominated the healthcare contract development and manufacturing organization market with the largest revenue share of 41.2% in 2019 owing to the presence of large number of CROs and CMOs in the region
• The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to low cost service offered by Asian CROs and CMOs
• Some of the key market players are Catalent Inc.; Lonza Group Ltd.; Recipharm AB; Siegfried Holding AG; Thermo Fisher Scientific Inc.; Covance Inc.; Jabil Inc.; Sanmina Corporation; IQVIA Holdings Inc.; and Flex Ltd.
To request research report sample copy with TOC please visit @: Healthcare Contract Development And Manufacturing Organization Market Report, 2027 (grandviewresearch.com)
Healthcare Contract Development & Manufacturing Organization Market Segmentation
Grand View Research has segmented the global healthcare contract development & manufacturing organization market based on services and region:
Healthcare Contract Development & Manufacturing Organization Services Outlook (Revenue, USD Billion, 2016 - 2027)
• Contract Development
o Preclinical
o Bioanalysis and DMPK studies
o Toxicology Testing
o Other Preclinical Services
o Clinical
o Phase I
o Phase II
o Phase III
o Phase IV
o Laboratory Services
o Bioanalytical Services
o Analytical Services
• Contract Manufacturing
o API/Bulk Drugs
o Finished Dose Formulations
o Medical Device
o Class I
o Class II
o Class III
Healthcare Contract Development & Manufacturing Organization Regional Outlook (Revenue, USD Billion, 2016 - 2027)
• North America
o U.S.
o Canada
• Europe
o U.K.
o Germany
o France
o Spain
o Italy
o Netherlands
o Belgium
o Switzerland
o Russia
o Sweden
• Asia Pacific
o India
o Japan
o China
o Australia
o South Korea
o Malaysia
o New Zealand
o Singapore
o Philippines
o Thailand
• Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Chile
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Israel
o Egypt
For Inquire before buying please visit @: Inquiry before buying Grand View Research San Francisco California
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.